XML 54 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Stock Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation
The impact of share-based compensation on the Company’s financial results is presented below:
For the Year Ended December 31,
(In thousands)202020192018
Share-based compensation expense$7,304 $7,244 $7,823 
Income tax benefit(1,737)(1,723)(1,911)
Schedule of Unrecognized Compensation Cost, Nonvested Awards
The total unrecognized compensation cost and the weighted-average period over which unrecognized compensation cost is expected to be recognized related to non-vested share-based compensation arrangements at December 31, 2020 is presented below:
(In thousands)Unrecognized
Compensation
Cost
Weighted-Average Period Remaining (Years)
Restricted stock awards$5,987 2.06
Restricted stock units3,153 1.93
Stock options96 0.25
Total$9,236 2.00
Schedule of Nonvested Share Activity
A summary of the status of the Company’s non-vested RSAs as of December 31, 2020, and changes during the year then ended, is presented below:
Restricted
Award
Shares
Weighted-Average Grant-Date Fair Value
Non-vested at January 1, 2020213,951 $26.07 
Granted379,869 18.36 
Forfeited/Canceled(11,064)22.19 
Vested(157,602)23.76 
Non-vested at December 31, 2020425,154 $20.03 
A summary of the status of the Company’s non-vested RSUs as of December 31, 2020, and changes during the year then ended, is presented below:
Restricted
Award
Shares
Weighted-Average Grant-Date Fair Value
Non-vested at January 1, 2020381,930 $23.86 
Granted171,287 17.29 
Forfeited/Canceled(12,597)21.55 
Vested(231,023)19.54 
Non-vested at December 31, 2020309,597 $23.54 
Schedule of Restricted Stock and Restricted Stock Units Activity
Information regarding restricted stock awards during each of the following years is presented below:
For the Year Ended December 31,
202020192018
Shares granted379,869 157,861 242,613 
Weighted-average grant date fair value$18.36 $26.86 $26.48 
Fair value of awards vested1
$3,745 $4,128 $2,515 
1Based on grant date fair value, in thousands
Information regarding restricted stock units during each of the following years is presented below:
For the Year Ended December 31,
202020192018
Shares granted171,287 75,002 173,193 
Weighted-average grant date fair value$17.29 $30.02 $24.02 
Fair value of awards vested1
$2,962 $2,864 $1,095 
1Based on grant date fair value, in thousands
Schedule of Stock Option Valuation Assumptions
The Company issued no stock options in 2020. In 2019 and 2018, the estimated the fair value of each option grant on the date of grant using the Black-Scholes options-pricing model with the following weighted-average assumptions:    
 For the Year Ended December 31,
 20192018
Risk-free interest rates2.53 %2.56 %
Expected dividend yield— %— %
Expected volatility34.50 %26.60 %
Expected lives (years)5.05.0
Schedule of Stock Options Roll Forward A summary of the Company’s stock options as of December 31, 2020, and changes during the year then ended, is presented below:
 OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term (Years)Aggregate
Intrinsic
Value
(000s)
Outstanding at January 1, 2020903,779 $22.22 
Granted— — 
Exercised(62,206)12.31 
Forfeited(1,689)29.30 
Outstanding at December 31, 2020839,884 $22.94 5.29$5,822 
Exercisable at December 31, 2020770,615 $22.20 5.125,822 
Schedule of Stock Option Activity nformation related to stock options during each of the following years:
For the Year Ended December 31,
202020192018
Options granted— 3,438 219,118 
Weighted-average grant date fair value$— $28.42 $5.65 
Intrinsic value of stock options exercised, in thousands830 277 3,045 
Schedule of Options Outstanding and Remaining Contractual Life of Stock Options
The following table summarizes information related to stock options as of December 31, 2020: 
Range of Exercise PricesOptions
Outstanding
Remaining
Contractual
Life (Years)
Options
Exercisable
Weighted
Average
Exercise
Price
$10.54 to $14.82
311,658 3.1311,658 $12.77 
$15.99 to $28.69
320,388 6.1320,388 27.51 
$31.15 to $31.15
207,838 7.3138,569 31.15 
Total839,884 5.3770,615 $22.20 
Schedule of Employee Stock Purchase Plan Activity Employee contributions to the ESPP are made through payroll deductions. 
 202020192018
ESPP shares purchased19,713 16,320 15,225 
Weighted-average employee purchase price$20.68 $25.39 $26.85